These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 863474)

  • 21. Complement-dependent inhibition of degradation of soluble immune complexes and immunoglobulin aggregates by thioglycollate-stimulated peritoneal macrophages.
    Daha MR; Van Es LA
    Immunology; 1983 Sep; 50(1):107-11. PubMed ID: 6224740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage triggering by aggregated immunoglobulins. I. Delayed effect of IgG aggregates or immune complexes.
    Pestel J; Joseph M; Dessaint JP; Capron A
    J Immunol; 1981 May; 126(5):1887-91. PubMed ID: 7217672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific in vivo inhibition of macrophage receptors for cytophilic antibody by soluble immune complexes.
    Rao VS; Grodzicki RL; Mitchell MS
    Cancer Res; 1979 Jan; 39(1):174-82. PubMed ID: 761189
    [No Abstract]   [Full Text] [Related]  

  • 24. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus.
    Kavai M; Szegedi G
    Autoimmun Rev; 2007 Aug; 6(7):497-502. PubMed ID: 17643939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of soluble immune complexes by human monocytes and pulmonary macrophages: effects of cigarette smoking.
    Cosio FG; Hoidal JR; Douglas SD; Michael AF
    J Lab Clin Med; 1982 Sep; 100(3):469-76. PubMed ID: 7108354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the cytotoxic activity of human lymphocytes. II. Interactions between IgG and Fc receptors leading to inhibition of K cell function.
    Ziegler HK; Henney CS
    J Immunol; 1977 Sep; 119(3):1010-7. PubMed ID: 894025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of sera from patients with connective tissue diseases on red cell binding and phagocytosis by monocytes.
    Temple A; Loewi G
    Immunology; 1977 Jul; 33(1):109-14. PubMed ID: 873570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of C1q, conglutinin and low affinity rabbit IgM antibody to human Fc in a ligand coctail radioassay for detecting and characterizing immune complexes in pathological sera.
    Harkiss GD; Brown DL
    Clin Exp Immunol; 1980 Mar; 39(3):576-82. PubMed ID: 7379330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced degradation of soluble immune complexes by guinea-pig peritoneal macrophages in the presence of complement.
    Kijlstra A; van Es LA; Daha MR
    Immunology; 1981 Jun; 43(2):345-52. PubMed ID: 7251057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune complexes and triggering of cellular mechanisms.
    Stanworth DR
    Haematologia (Budap); 1978-1979; 12(1-4):47-54. PubMed ID: 395042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mononuclear phagocyte system in SLE. II. A kinetic model of immune complex handling in systemic lupus erythematosus.
    Meryhew NL; Kimberly RP; Messner RP; Runquist OA
    J Immunol; 1986 Jul; 137(1):97-102. PubMed ID: 3486919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of B cell cytotoxicity by aggregated IgG and immune complexes.
    d'Apice AJ; Tait BD; Lambert G
    Tissue Antigens; 1977 Nov; 10(5):273-8. PubMed ID: 305139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of circulating antigen-antibody complexes by precipitation with C1q and polyethylene glycol].
    Nydegger U; Gerber H; Lambert PH; Miescher PA
    Schweiz Med Wochenschr; 1974 Jan; 104(4):126-7. PubMed ID: 4544103
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune complexes bind to cultured rat glomerular mesangial cells to stimulate superoxide release. Evidence for an Fc receptor.
    Sedor JR; Carey SW; Emancipator SN
    J Immunol; 1987 Jun; 138(11):3751-7. PubMed ID: 3035013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH; Lange G; Lambert PH; Miescher PA
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
    Atkins KL; Burman JD; Chamberlain ES; Cooper JE; Poutrel B; Bagby S; Jenkins AT; Feil EJ; van den Elsen JM
    Mol Immunol; 2008 Mar; 45(6):1600-11. PubMed ID: 18061675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.